Free Trial

U.S. Physical Therapy (USPH) Stock Price, News & Analysis

-2.57 (-2.49%)
(As of 05/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
69,509 shs
Average Volume
58,954 shs
Market Capitalization
$1.51 billion
P/E Ratio
Dividend Yield
Price Target

U.S. Physical Therapy MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
25.0% Upside
$125.67 Price Target
Short Interest
4.69% of Shares Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
0.70mentions of U.S. Physical Therapy in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$1.85 M Sold Last Quarter
Proj. Earnings Growth
From $2.90 to $3.16 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.61 out of 5 stars

Medical Sector

376th out of 915 stocks

Health Services Industry

4th out of 10 stocks

USPH stock logo

About U.S. Physical Therapy Stock (NYSE:USPH)

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

USPH Stock Price History

USPH Stock News Headlines

Q1 2024 US Physical Therapy Inc Earnings Call
U.S. Physical Therapy: Q1 Earnings Snapshot
What Wall Street expects from US Physical Therapy's earnings
U.S. Physical Therapy Announces Acquisitions
See More Headlines
Receive USPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for U.S. Physical Therapy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/5 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 6/14 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Health services
Health Care Facilities
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
4 Analysts


Net Income
$28.24 million
Pretax Margin


Sales & Book Value

Annual Sales
$611.97 million
Cash Flow
$4.43 per share
Book Value
$31.94 per share


Free Float
Market Cap
$1.51 billion
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

USPH Stock Analysis - Frequently Asked Questions

Should I buy or sell U.S. Physical Therapy stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" USPH shares.
View USPH analyst ratings
or view top-rated stocks.

What is U.S. Physical Therapy's stock price target for 2024?

4 Wall Street research analysts have issued 12-month target prices for U.S. Physical Therapy's shares. Their USPH share price targets range from $117.00 to $138.00. On average, they anticipate the company's stock price to reach $125.67 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for USPH
or view top-rated stocks among Wall Street analysts.

How have USPH shares performed in 2024?

U.S. Physical Therapy's stock was trading at $93.14 at the beginning of 2024. Since then, USPH shares have increased by 7.9% and is now trading at $100.53.
View the best growth stocks for 2024 here

When is U.S. Physical Therapy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our USPH earnings forecast

How were U.S. Physical Therapy's earnings last quarter?

U.S. Physical Therapy, Inc. (NYSE:USPH) announced its earnings results on Tuesday, May, 7th. The company reported $0.51 earnings per share for the quarter, missing analysts' consensus estimates of $0.58 by $0.07. The business earned $155.70 million during the quarter, compared to analyst estimates of $153.30 million. U.S. Physical Therapy had a trailing twelve-month return on equity of 8.03% and a net margin of 4.72%. U.S. Physical Therapy's revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period last year, the firm earned $0.59 earnings per share.

How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?

U.S. Physical Therapy announced a quarterly dividend on Tuesday, May 7th. Stockholders of record on Thursday, May 23rd will be paid a dividend of $0.44 per share on Friday, June 14th. This represents a $1.76 annualized dividend and a yield of 1.75%. The ex-dividend date is Wednesday, May 22nd.
Read our dividend analysis for USPH

Is U.S. Physical Therapy a good dividend stock?

U.S. Physical Therapy (NYSE:USPH) pays an annual dividend of $1.76 per share and currently has a dividend yield of 1.71%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 143.09%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, USPH will have a dividend payout ratio of 55.70% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for USPH.

What is Chris Reading's approval rating as U.S. Physical Therapy's CEO?

38 employees have rated U.S. Physical Therapy Chief Executive Officer Chris Reading on Chris Reading has an approval rating of 49% among the company's employees. This puts Chris Reading in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of U.S. Physical Therapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other U.S. Physical Therapy investors own include Pfizer (PFE), NVIDIA (NVDA), AbbVie (ABBV), CVS Health (CVS), Gilead Sciences (GILD), International Business Machines (IBM), Illumina (ILMN), Johnson & Johnson (JNJ), Lowe's Companies (LOW) and Marathon Petroleum (MPC).

Who are U.S. Physical Therapy's major shareholders?

U.S. Physical Therapy's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.12%), Riverbridge Partners LLC (2.50%), Bahl & Gaynor Inc. (0.70%), Principal Financial Group Inc. (0.54%), Sei Investments Co. (0.53%) and Silvercrest Asset Management Group LLC (0.48%). Insiders that own company stock include Anne Motsenbocker, Carey P Hendrickson, Christopher J Reading, Clayton Trier, Edward L Kuntz, Eric Joseph Williams, Glenn Mcdowell, Graham D Reeve, Harry S Chapman, Harry S Chapman, Kathleen A Gilmartin, Mark J Brookner and Richard Binstein.
View institutional ownership trends

How do I buy shares of U.S. Physical Therapy?

Shares of USPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:USPH) was last updated on 5/24/2024 by Staff

From Our Partners